Uceris
Uceris Uceris (misoprostol) is a synthetic prostaglandin E1 analog used primarily for the prevention of NSAID‑induced peptic ulcers, treatment of gastric ulcers, and certain obstetrical indications. Mechanism of Action Stimulation…
Ubrogepant
Ubrogepant Mechanism of Action Ubrogepant is a selective, non‑peptide calcitonin gene‑related peptide (CGRP) receptor antagonist. By competitively binding to the CGRP receptor located on trigeminal neuronal cells, it blocks CGRP‑mediated…
Ubrelvy
Ubrelvy Ubrelvy (lasmiditan) is the first selective serotonin 5‑HT1F receptor agonist approved for the acute treatment of migraine. It differs from triptans in that it does not elicit vasoconstriction, making…
Ublituximab
Ublituximab Ublituximab is a humanized IgG1 kappa monoclonal antibody (mAb) that targets the B‑cell surface antigen CD20. It has been developed for B‑cell–mediated disorders such as rheumatoid arthritis (RA) and…
Ubiquinone
Ubiquinone Ubiquinone (coenzyme Q10 or CoQ10) is a fat‑soluble antioxidant that functions as a key component of the mitochondrial respiratory chain and as an electron carrier in cellular bioenergetics. Mechanism…
Tysabri
Tysabri Tysabri (natalizumab) is a humanized monoclonal antibody that targets the α4-integrin subunit, used primarily for relapsing‑remitting multiple sclerosis (RR‑MS) and moderately severe Crohn’s disease. Mechanism of Action α4‑integrin blockade:…
Tyrvaya
Tyrvaya Tyrvaya (lenvatinib) is an oral multitargeted tyrosine‑kinase inhibitor (TKI) approved for the treatment of metastatic renal cell carcinoma (mRCC) and differentiated thyroid cancer refractory to radioactive iodine. It selectively…
Tylenol
Tylenol Mechanism of Action Acetaminophen (the active ingredient in Tylenol) primarily acts as a CNS‑centered inhibitor of cyclo‑oxygenase (COX) enzymes, with a strong preference for COX‑2 over COX‑1 in the…
Twirla
Twirla Twirla is a novel orally administered, small‐molecule antidepressant that combines serotonin reuptake inhibition with dopamine D2 partial agonism and 5‑HT2A antagonism, offering rapid mood elevation and appetite suppression. It…
Tryngolza
Tryngolza Tryngolza (generic: tabrichilin) is a selective Jak1/Jak2 inhibitor approved for moderate‑to‑severe rheumatoid arthritis (RA) and psoriatic arthritis (PsA). It belongs to the novel class of targeted synthetic disease‑modifying antirheumatic…